paperKB
coga / coga-kb
Help
Sign in

Chunk #129 — Results — Levels and trends in the burden attributable to risk factors

Source
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
Embedded
yes

Text

Tuberculosis without extensive drug resistance2·54 (1·51 to 4·11)1·20 (0·70 to 1·95)–52·97 (−60·55 to −44·20)*–59·62 (−66·05 to −52·09)*118·88 (70·41 to 191·24)56·61 (33·39 to 90·84)–52·38 (−60·30 to −43·58)*–58·61 (−65·43 to −50·96)*··Extensively drug-resistant HIV/AIDS - Tuberculosis0·20 (0·12 to 0·33)0·29 (0·16 to 0·47)44·03 (18·74 to 75·38)*25·61 (3·55 to 52·91)*9·74 (5·65 to 16·23)13·91 (7·92 to 22·69)42·89 (17·38 to 74·95)*25·59 (3·29 to 53·36)*··HIV/AIDS resulting in other diseases74·37 (58·68 to 92·92)53·21 (43·04 to 65·66)–28·45 (−33·86 to −21·66)*–38·29 (−42·87 to −32·58)*3651·47 (2871·87 to 4584·05)2670·75 (2142·39 to 3303·74)–26·86 (−31·94 to −20·21)*–36·29 (−40·83 to −30·65)*··Hepatitis B0·32 (0·25 to 0·41)0·31 (0·24 to 0·40)–1·97 (−9·09 to 5·66)–20·37 (−26·08 to −14·19)*12·08 (9·29 to 15·29)11·54 (8·88 to 14·71)–4·47 (−12·19 to 3·69)–20·80 (−27·31 to −14·08)*··Hepatitis C0·42 (0·32 to 0·54)0·48 (0·37 to 0·62)14·60 (−1·60 to 33·24)–6·68 (−19·61 to 8·34)16·51 (12·58 to 21·05)18·25 (13·84 to 23·78)10·51 (−3·77 to 27·77)–6·31 (−18·68 to 7·88)··Liver cancer due to hepatitis B1·52 (1·16 to 1·99)2·56 (1·97 to 3·32)68·29 (57·54 to 79·01)*33·74 (25·83 to 41·46)*49·42 (37·44 to 64·43)78·10 (59·59 to 101·47)58·03 (46·77 to 68·88)*28·05 (19·75 to 36·41)*··Liver cancer due to hepatitis C37·35 (31·94 to 43·13)62·46 (54·75 to 70·85)67·23 (59·37 to 75·65)*30·03 (23·93 to 36·56)*998·00 (853·25 to 1148·69)1558·54 (1357·79 to 1774·17)56·17 (48·56 to 63·89)*23·45 (17·44 to 29·28)*··Cirrhosis and other chronic liver diseases due to